Zynlonta

Medicinal product

(Invented) name

Zynlonta

Active substance (s)

Lonkastuksimabas tesirinas

Strength

10 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FX22, loncastuximab tesirine

Marketing authorisation holder

Swedish Orphan Biovitrum AB (publ), Švedija

Date of authorisation

2022-12-20

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate for solution for infusion	1 vnt.
Lonkastuksimabas tesirinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110929	97040	1097040	flakonas	N1		Receptinis	EU/1/22/1695/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-12-20	Registruotas